Alert: New Earnings Report (11/4/24)-TG Therapeutics Inc (NASDAQ: TGTX).
TG Therapeutics Inc (NASDAQ: TGTX) has reported E.P.S. of $0.03 for its third fiscal quarter (ending September 30) versus $0.80 for the same period a year ago — a decline of -96%. For the latest […]